Concepedia

Publication | Closed Access

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

DOI

379

Citations

18

References

1999

Year

A. Michael Lincoff, Robert M. Califf, David J. Moliterno, Stephen G. Ellis, John Ducas, Jeffrey H Kramer, Neal S. Kleiman, Eric A. Cohen, Joan E. Booth, Shelly Sapp,
New England Journal of Medicine

Abstract

For coronary revascularization, abciximab and stent implantation confer complementary long-term clinical benefits.

References

YearCitations

Page 1